{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:58:13Z","timestamp":1773748693875,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.euf.2025.10.014","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:30:00Z","timestamp":1765420200000},"page":"237-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer\u2014Oncological Outcome from Long-term Follow-up"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2178-5586","authenticated-orcid":false,"given":"Ruth","family":"Himmelsbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon K.B.","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Franz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Astheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Grabbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August","family":"Sigle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schultze-Seemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula A.","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.10.014_b0005","unstructured":"EAU. EAU guidelines. Presented at the EAU Annual Congress Paris; 2024."},{"key":"10.1016\/j.euf.2025.10.014_b0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.eururo.2014.03.019","article-title":"Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy","volume":"67","author":"Abdollah","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.juro.2014.08.082","article-title":"Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography\/computerized tomography","volume":"193","author":"Karnes","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eururo.2014.02.011","article-title":"Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years","volume":"67","author":"Suardi","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.juro.2014.08.096","article-title":"Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy","volume":"193","author":"Tilki","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2018.10.041","article-title":"Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review","volume":"76","author":"Ploussard","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0040","series-title":"EAU - ESTRO - SIOG guidelines on prostate cancer","author":"Mottet","year":"2016"},{"key":"10.1016\/j.euf.2025.10.014_b0045","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.juro.2012.08.041","article-title":"Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer","volume":"188","author":"Jilg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0050","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.7150\/thno.18421","article-title":"Diagnostic accuracy of Ga-68-HBED-CC-PSMA-ligand-PET\/CT before salvage lymph node dissection for recurrent prostate cancer","volume":"7","author":"Jilg","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.euf.2025.10.014_b0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.euf.2025.10.014_b0060","unstructured":"Astellas Pharma US, Inc. Statistical analysis plan for study 9785-CL-0410 (EMBARK): enzalutamide in men with nonmetastatic hormone-sensitive prostate cancer (nmHSPC) progressing after primary treatment. 2019. https:\/\/clinicaltrialsgov\/ProvidedDocs\/37\/NCT02319837\/SAP_001pdf."},{"key":"10.1016\/j.euf.2025.10.014_b0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2020.06.043","article-title":"Long-term outcomes of salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy: not as good as previously thought","volume":"78","author":"Bravi","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0075","doi-asserted-by":"crossref","first-page":"84180","DOI":"10.18632\/oncotarget.21118","article-title":"Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET\/CT for nodal recurrence in prostate cancer patients","volume":"8","author":"Herlemann","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2025.10.014_b0080","doi-asserted-by":"crossref","unstructured":"Falkenbach F, Lischewski F, Knipper S, et al. Prostate-specific membrane antigen-radioguided surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2025.01.006.","DOI":"10.1016\/j.euf.2025.01.006"},{"key":"10.1016\/j.euf.2025.10.014_b0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/iju.15066","article-title":"Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy","volume":"30","author":"Van Eecke","year":"2023","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.23736\/S2724-6051.23.05445-9","article-title":"Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer","volume":"75","author":"Ambrosini","year":"2023","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.euf.2025.10.014_b0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JU.0000000000000800","volume":"204","author":"Fossati","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial","volume":"26","author":"Ost","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2025.10.014_b0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2018.04.017","article-title":"Impact of adjuvant radiotherapy in node-positive prostate cancer patients: the importance of patient selection","volume":"74","author":"Abdollah","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0110","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.euf.2016.01.008","article-title":"Mid-term outcomes following salvage lymph node dissection for prostate cancer nodal recurrence status post-radical prostatectomy","volume":"2","author":"Zattoni","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.10.014_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/pcan.2016.54","article-title":"The role of salvage extended lymph node dissection in patients with rising PSA and PET\/CT scan detected nodal recurrence of prostate cancer","volume":"20","author":"Porres","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2025.10.014_b0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.10.014_b0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.10.014_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euf.2025.10.014_b0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7150\/thno.16638","article-title":"Comparison of (68)Ga-HBED-CC PSMA-PET\/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology","volume":"7","author":"Zamboglou","year":"2017","journal-title":"Theranostics"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:59:07Z","timestamp":1773745147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2405456925003001"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.10.014","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer\u2014Oncological Outcome from Long-term Follow-up","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}